Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Firefly Neuroscience (AIFF) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Firefly Neuroscience (AIFF) over the last 15 years, with Q3 2025 value amounting to -$1.6 million.

  • Firefly Neuroscience's Free Cash Flow rose 3761.4% to -$1.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$7.8 million, marking a year-over-year decrease of 4128.74%. This contributed to the annual value of -$6.3 million for FY2024, which is 19019.34% down from last year.
  • According to the latest figures from Q3 2025, Firefly Neuroscience's Free Cash Flow is -$1.6 million, which was up 3761.4% from -$2.4 million recorded in Q2 2025.
  • In the past 5 years, Firefly Neuroscience's Free Cash Flow registered a high of $491536.0 during Q3 2023, and its lowest value of -$2.9 million during Q4 2022.
  • For the 5-year period, Firefly Neuroscience's Free Cash Flow averaged around -$1.3 million, with its median value being -$1.3 million (2024).
  • In the last 5 years, Firefly Neuroscience's Free Cash Flow skyrocketed by 15486.69% in 2021 and then plummeted by 133797.73% in 2022.
  • Over the past 5 years, Firefly Neuroscience's Free Cash Flow (Quarter) stood at -$322949.0 in 2021, then plummeted by 793.73% to -$2.9 million in 2022, then surged by 82.33% to -$510000.0 in 2023, then plummeted by 154.51% to -$1.3 million in 2024, then fell by 21.26% to -$1.6 million in 2025.
  • Its Free Cash Flow was -$1.6 million in Q3 2025, compared to -$2.4 million in Q2 2025 and -$2.5 million in Q1 2025.